share_log

Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7

Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7

Leerink Partners以跑赢大盘的评级启动对Tenaya Therapeutics的报道,宣布目标股价为7美元
Benzinga ·  2023/11/30 08:46

Leerink Partners analyst Mani Foroohar initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Outperform rating and announces Price Target of $7.

Leerink Partners分析师玛尼·福鲁哈尔以跑赢大盘的评级开始对Tenaya Therapeutics(纳斯达克股票代码:TNYA)进行报道,并宣布目标股价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发